Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals.
J Clin Sleep Med
; 18(2): 373-382, 2022 02 01.
Article
em En
| MEDLINE
| ID: mdl-34314346
ABSTRACT
STUDY OBJECTIVES:
To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on insomnia and other sleep disturbances in health care professionals.METHODS:
A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, sex, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares, and snoring (secondary outcomes).RESULTS:
A total of 4,384 health professionals from all regions of the country were included in the analysis (44 ± 12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents in parallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported ≥ 1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (odds ratio [OR] 1.008; 95% confidence interval [CI] 1.001-1.015), females (OR 1.590; 95% CI 1.335-1.900), weight change (decrease OR 1.772; 95% CI 1.453-2.161; increase OR 1.468; 95% CI 1.249-1.728), prevalent anxiety (OR 3.414; 95% CI 2.954-3.948), new-onset burnout (OR 1.761; 95% CI 1.489-2.083), family income reduction > 30% (OR 1.288; 95% CI 1.069-1.553), and assisting patients with COVID-19 (OR 1.275; 95% CI 1.081-1.506) were independently associated with new-onset or worsening of previous insomnia episodes.CONCLUSIONS:
We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic. CITATION Drager LF, Pachito DV, Moreno CRC, et al. Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic a nationwide cross-sectional study in Brazilian health care professionals. J Clin Sleep Med. 2022;18(2)373-382.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Distúrbios do Início e da Manutenção do Sono
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
Revista:
J Clin Sleep Med
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA